Matthew Clark, Author at Money & Markets

Author: Matthew Clark

Cut Through the Vaccine Hype With This Biotech Buy

Posted by Matthew Clark | Oct 10, 2020 | Investing

Companies are searching for a COVID-19 treatment. We found one vaccine stock to buy now in this week’s episode of The Bull & The Bear.

Posted by Matthew Clark | Oct 9, 2020 | Investing

Cannabis stock HEXO Corp. has partnered with Molson Coors. HEXO stock struggles, but could the Coors venture be its needed shot in the arm?

This is the one COVID-19 vaccine stock that you should stay away from at all costs. The deck is stacked against one company in particular.

Posted by Matthew Clark | Oct 6, 2020 | Investing

One election ETF to buy that will stand up no matter who wins in November. Find out the election-proof stock to buy today.

Posted by Matthew Clark | Oct 4, 2020 | Markets, Podcast

In this edition of the Money & Markets Week Ahead, Matt talks about a SPAC launching Monday and the slew of economic data coming soon.